US Food and Drug Administration Commissioner Robert Califf expects to spend about a year developing a strategy to combat medical product misinformation, an effort that will involve public meetings.
At recent events sponsored by Health Affairs and the Alliance for Health Policy, Califf talked about addressing misinformation as one of his overarching priorities, and one for which he put a stake in the ground in his first days as commissioner
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?